← Back to Clinical Trials
Recruiting NCT06490861

NCT06490861 Performance of the Paragit Sleeve to Measure and Monitor Motor Symptoms in Patients With Parkinson's Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06490861
Status Recruiting
Phase
Sponsor Paragit ApS
Condition Parkinson Disease
Study Type INTERVENTIONAL
Enrollment 25 participants
Start Date 2023-12-19
Primary Completion 2024-08-01

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Paragit

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 25 participants in total. It began in 2023-12-19 with a primary completion date of 2024-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This investigation is undertaken to: * Evaluate the accuracy and reliability of the device in measuring and recording motor symptoms associated with Parkinson's Disease (PD), and * To assess the safety and tolerability of the device in patients with PD.

Eligibility Criteria

Inclusion Criteria: 1. Parkinson disease: Clinically diagnosed 2. Age ≥ 50 (not in the childbearing aged as defined by Statistics Denmark, 15-49) 3. Experiencing at least two of following symptoms and/or side effect on a daily basis: * Rigidity * Tremor * Bradykinesia * Dyskinesia (treatment side effect) 4. Provision of informed consent, i.e., the subject must be able to: * Read and understand the Patient Information and Consent Form * Sign the Patient Information and Consent Form. Exclusion Criteria: 1. Known allergy/hypersensitivity to any material in direct contact with the skin (stainless steel, silicone and polyester) 2. MMSE \<24 3. Other neurological diseases

Frequently Asked Questions

Who can join the NCT06490861 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06490861 currently recruiting?

Yes, NCT06490861 is actively recruiting participants. Visit ClinicalTrials.gov or contact Paragit ApS to inquire about joining.

Where is the NCT06490861 trial being conducted?

This trial is being conducted at Madrid, Spain.

Who is sponsoring the NCT06490861 clinical trial?

NCT06490861 is sponsored by Paragit ApS. The trial plans to enroll 25 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology